Suppr超能文献

在毕赤酵母中高效生产分泌型棒状链霉菌β-内酰胺酶抑制蛋白(BLIP)。

Efficient production of secretory Streptomyces clavuligerus β-lactamase inhibitory protein (BLIP) in Pichia pastoris.

作者信息

Law Kin-Ho, Tsang Man-Wah, Wong Yuk-Ki, Tsang Ming-San, Lau Pui-Yee, Wong Kwok-Yin, Ho Kwok-Ping, Leung Yun-Chung

机构信息

Department of Applied Biology and Chemical Technology and the State Key Laboratory of Chirosciences, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong, China.

Lo Ka Chung Centre for Natural Anti-Cancer Drug Development, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong, China.

出版信息

AMB Express. 2018 Apr 20;8(1):64. doi: 10.1186/s13568-018-0586-3.

Abstract

β-Lactamase inhibitory protein (BLIP), a low molecular weight protein from Streptomyces clavuligerus, has a wide range of potential applications in the fields of biotechnology and pharmaceutical industry because of its tight interaction with and potent inhibition on clinically important class A β-lactamases. To meet the demands for considerable amount of highly pure BLIP, this study aimed at developing an efficient expression system in eukaryotic Pichia pastoris (a methylotrophic yeast) for production of BLIP. With methanol induction, recombinant BLIP was overexpressed in P. pastoris X-33 and secreted into the culture medium. A high yield of ~ 300 mg/L culture secretory BLIP recovered from the culture supernatant without purification was found to be > 90% purity. The recombinant BLIP was fully active and showed an inhibition constant (K) for TEM-1 β-lactamase (0.55 ± 0.07 nM) comparable to that of the native S. clavuligerus-expressed BLIP (0.5 nM). Yeast-produced BLIP in combination with ampicillin effectively inhibited the growth of β-lactamase-producing Gram-positive Bacillus. Our approach of expressing secretory BLIP in P. pastoris gave 71- to 1200-fold more BLIP with high purity than the other conventional methods, allowing efficient production of large amount of highly pure BLIP, which merits fundamental science studies, drug development and biotechnological applications.

摘要

β-内酰胺酶抑制蛋白(BLIP)是一种来自克拉维链霉菌的低分子量蛋白质,由于其与临床上重要的A类β-内酰胺酶紧密相互作用并具有强效抑制作用,在生物技术和制药工业领域具有广泛的潜在应用。为了满足对大量高纯度BLIP的需求,本研究旨在开发一种在真核毕赤酵母(一种甲基营养型酵母)中的高效表达系统来生产BLIP。通过甲醇诱导,重组BLIP在毕赤酵母X-33中过表达并分泌到培养基中。从培养上清液中回收的未经纯化的分泌型BLIP产量高达约300 mg/L,纯度>90%。重组BLIP具有完全活性,对TEM-1β-内酰胺酶的抑制常数(K)为(0.55±0.07 nM),与天然克拉维链霉菌表达的BLIP(0.5 nM)相当。酵母产生的BLIP与氨苄青霉素联合使用可有效抑制产β-内酰胺酶的革兰氏阳性芽孢杆菌的生长。我们在毕赤酵母中表达分泌型BLIP的方法比其他传统方法产生的高纯度BLIP多71至1200倍,能够高效生产大量高纯度的BLIP,这对基础科学研究、药物开发和生物技术应用具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e88/5910447/0c08010d511a/13568_2018_586_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验